1. Home Page
  2. For Patients & Caregivers
  3. Learn About Cancers and Treatments
  4. Innovation at The James
  5. Clinical Trials
  6. Find a Clinical Trial
  7. A Phase Iphase II Openlabel Multicenter
All Clinical Trials

OSU-24210: SAR443579 Comb Aza + Venet Adlt CD123 ND-AML Ineligible Intensive Chemo - Substudy 01

Study Status Open To Accrual
National Clinical Trial Identifier NCT06508489
Phase I/II
  • Full Title

    A Phase I/Phase II, Open-Label, Multi-Center Study, Assessing the Safety, Tolerability and the Preliminary Efficacy of SAR443579 Administered in Combination with Azacitidine + Venetoclax in Adult Participants with CD123 Expressing Newly Diagnosed Acute Myeloid Leukemia (ND-AML) that are Ineligible for Intensive Chemotherapy - Substudy 01

  • Resources & Links
  • Interested in this Trial?
    If you are interested in participating in this study, call The JamesLine at 800-293-5066 to make an appointment with the principal investigator listed or ask your doctor if you are eligible for this study.

Trial Information

Protocol Number:OSU-24210
Gender:All
Disease Group:AML

Questions

If you are interested in participating in this study, call The JamesLine at 800-293-5066 to make an appointment with the principal investigator listed or ask your doctor if you are eligible for this study.